StockWatch
·

EMAMI LTD.-$

BSE: 531162

P/L Snapshot

Q1 FY27 · standalone

vs Q4 FY26·vs Q1 FY26
Revenue
833.10
+10.5%+7.2%
Expenditure
599.50
+5.3%+0.6%
Net Profit
182.22
+9.5%+11.7%
OPM %
27.62%
+0.69pp+1.11pp

Shareholding

Pattern breakdown

P/L Trends

(in crores)

RevenueExpenditureNet Profit
0.00273.54547.08820.621.1KQ2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Price Chart
Latest News
Board Meeting4 Aug, 1:51 pm

Emami Q1 FY27: consolidated revenue up 15% YoY, but PAT falls 15% on margin, tax swing

Emami's consolidated (primary basis) revenue rose 14.9% YoY to ₹1,039 Cr (+12.3% QoQ), but consolidated PAT fell 15.4% YoY to ₹138.9 Cr (-2.9% QoQ), missing our pre-result Street consensus (revenue ~₹1,055 Cr — roughly in line, -1.5%; EPS ~₹4.36 vs actual ₹3.15 — a clear miss). This is the first print to consolidate Axiom Ayurveda (from April 1) and IncNut Digital (60% stake, from June 1), so YoY comparisons are not fully like-for-like. The PAT decline is driven by two distinct effects. First, genuine operating margin compression: OPM fell to 21.8% from 23.7% YoY (though it expanded from 20.2% QoQ), and NPM fell to 13.1% from 17.7% YoY, on higher advertisement/promotion spend (₹203 Cr vs ₹180 Cr YoY) and employee costs (₹136 Cr vs ₹119 Cr YoY), alongside finance costs more than doubling YoY to ₹5.6 Cr on acquisition funding (₹100 Cr first tranche for Axiom's remaining 73.5% stake; ₹321 Cr for IncNut's 60% stake). Second, a tax-line swing: PBT before exceptional items actually rose 4.2% YoY to ₹194.7 Cr, but tax expense jumped to ₹55.8 Cr from ₹22.5 Cr as MAT credit accounting flipped from a ₹10.4 Cr benefit a year ago to a ₹13.5 Cr utilisation charge this quarter — a ~₹23.8 Cr negative swing that alone accounts for most of the increase in tax outgo. Stripping this MAT-line effect out, adjusted PAT is roughly flat YoY (-1.0%) rather than -15.4% reported, though the underlying operating-margin compression is real and independent of the tax effect. Management's prior (Q4 FY26) guidance flagged margin improvement via cost discipline and a 3% price hike, and double-digit summer-portfolio growth for FY27; this quarter's revenue growth is consistent with that confidence, but the YoY margin compression runs counter to the margin-improvement guidance — a miss on that specific commitment, at least for Q1. International business was guided to return to double-digit growth only from Q2 FY27, so its Q1 trajectory (not separately disclosed here) is not yet a test of that promise. Standalone (core Emami, ex-new subsidiaries) PAT was ₹182.2 Cr with EPS ₹4.17, and its PBT of ₹233.6 Cr grew against a stronger base — a cleaner read on the core business than the consolidated number, which is now diluted by two newly acquired, lower-margin/loss-making entities: IncNut's first stub period (June 1-30) contributed a ₹0.9 Cr net loss on ₹14.7 Cr revenue. No management press release commentary was available in the extracted materials to corroborate these drivers independently. Going into Q2 FY27, the two things to verify are whether the tax-line swing normalizes (this quarter's effective rate was 28.6% vs 12.1% a year ago) and whether international revenue delivers the double-digit growth management guided for from Q2 onward, alongside the first full quarter of IncNut/Axiom integration and their margin trajectory.

4 Aug 2026, 01:51 pm

Corporate Events

Board MeetingEMAMILTD
2026
25Aug

Board Meeting

The 43rd Annual General Meeting will be held to transact ord…

BSE Filing
Board MeetingEMAMILTD
2026
4Aug

Board Meeting

The meeting of the Board of Directors of the Company will be…

BSE Filing
Board MeetingEMAMILTD
2025
16May

Board Meeting

Consideration of declaration of 3rd Interim Dividend for the…

BSE Filing
DividendEMAMILTD
2025
4Feb

₹2 / share

BSE Filing
DividendEMAMILTD
2024
18Nov

₹25 / share

BSE Filing
Board MeetingEMAMILTD
2024
1Aug

Board Meeting

Consider and approve unaudited standalone and consolidated f…

BSE Filing
Board MeetingEMAMILTD
2024
29May

Board Meeting

Consider and approve Audited standalone and consolidated fin…

BSE Filing
DividendEMAMILTD
2024
19Feb

₹0.004 / share

BSE Filing
Board MeetingEMAMILTD
2024
9Feb

Board Meeting

Consider and approve Unaudited Standalone and Consolidated F…

BSE Filing
DividendEMAMILTD
2023
15Nov

₹0.004 / share

BSE Filing
Board MeetingEMAMILTD
2023
6Nov

Board Meeting

Consider and approve unaudited standalone and consolidated f…

BSE Filing